ANIK   $15.63  -1.94% Market Closed After Close 15.57 -0.38%

Anika Therapeutics Inc
Total Cash 62.82M
totalCashPerShare 4.246
EBITDA 11.29M
Total Debt 28.08M
quickRatio 3.698
currentRatio 5.934
Total Revenue 166.88M
debtToEquity 13.348
Revenue/Share 11.349
ROA 0.00011
ROE -0.30629998
grossProfits
freeCashflow 15.75M
operatingCashflow 8.93M
earningsGrowth
revenueGrowth -0.054
grossMargins 0.62611
ebitdaMargins 0.06765
operatingMargins 0.0038400001
profitMargins -0.4445
enterpriseValue 330.44M
forwardPE 184.99998
floatShares 10.78M
sharesOutstanding 14.80M
sharesShort 489.05K
sharesShortPriorMonth 673.26K
dateShortInterest
sharesPercentSharesOut 0.03%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.92%
Short Ratio help_outline 7.63%
shortPercentOfFloat 0.05%
impliedSharesOutstanding
bookValue 14.479
Price To Book help_outline 1.15
earningsQuarterlyGrowth
netIncomeToCommon -74.18M
trailingEps -5.06%
forwardEps 0.09%
enterpriseToEbitda 29.27
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.11 4Q 2024
institutionsCount 169
lastUpdated Nov. 1, 2024, 6:24 p.m.